VAIRA, BERARDINO
 Distribuzione geografica
Continente #
EU - Europa 7.174
NA - Nord America 6.840
AS - Asia 1.640
AF - Africa 213
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 8
Totale 15.919
Nazione #
US - Stati Uniti d'America 6.827
IT - Italia 2.798
GB - Regno Unito 1.492
DE - Germania 702
CN - Cina 673
SE - Svezia 649
VN - Vietnam 473
UA - Ucraina 422
IN - India 297
FR - Francia 237
IE - Irlanda 236
RU - Federazione Russa 201
ZA - Sudafrica 122
BG - Bulgaria 116
EE - Estonia 112
JO - Giordania 87
CH - Svizzera 53
FI - Finlandia 43
SC - Seychelles 35
SG - Singapore 35
TG - Togo 27
BE - Belgio 23
CI - Costa d'Avorio 20
BR - Brasile 18
EU - Europa 16
GR - Grecia 16
JP - Giappone 16
NL - Olanda 16
AL - Albania 12
LB - Libano 12
TR - Turchia 12
AT - Austria 10
CA - Canada 10
ES - Italia 9
LY - Libia 8
IR - Iran 6
AU - Australia 5
CZ - Repubblica Ceca 5
RO - Romania 5
HK - Hong Kong 4
HR - Croazia 4
IL - Israele 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
NZ - Nuova Zelanda 3
PL - Polonia 3
PS - Palestinian Territory 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
KR - Corea 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
TW - Taiwan 2
AR - Argentina 1
CR - Costa Rica 1
GL - Groenlandia 1
HU - Ungheria 1
ID - Indonesia 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MM - Myanmar 1
MT - Malta 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
SI - Slovenia 1
TL - Timor Orientale 1
UZ - Uzbekistan 1
Totale 15.919
Città #
Southend 1.352
Fairfield 814
Chandler 673
Ashburn 483
Woodbridge 416
Wilmington 398
Seattle 370
Princeton 367
Houston 348
Jacksonville 289
Cambridge 283
Ann Arbor 249
Dong Ket 246
Dublin 236
Milan 226
Bologna 212
Padova 156
Rome 149
Westminster 149
Nanjing 145
Sofia 116
Berlin 113
Amman 87
New York 79
Naples 74
Turin 72
Saint Petersburg 69
Jinan 63
Shenyang 62
Tappahannock 60
San Diego 58
Mülheim 57
Nanchang 55
Frattamaggiore 50
Beijing 47
Redmond 41
Changsha 38
Hebei 36
Dearborn 33
Mahé 33
Des Moines 32
Helsinki 32
Verona 32
Bari 31
Florence 31
Tianjin 31
Boydton 28
Catania 28
Lomé 27
Medford 24
Zhengzhou 24
Mountain View 22
Palermo 22
Abidjan 20
Bern 20
Boardman 20
Brussels 20
Genoa 20
Norwalk 18
Hangzhou 17
Los Angeles 17
Redwood City 17
Singapore 17
Brescia 16
Haikou 16
Imola 16
San Venanzo 16
Guangzhou 15
Taiyuan 15
Livorno 14
Napoli 14
Tokyo 14
Kunming 13
Reggio Emilia 13
Faenza 12
Falls Church 12
Forlì 12
Jiaxing 12
Olalla 12
Parma 12
Venice 12
Bühl 11
Trieste 11
Lanzhou 10
Lappeenranta 10
Paris 10
São Paulo 10
Taizhou 10
Valsamoggia 10
Campobasso 9
Hyderabad 9
Ningbo 9
Carpi 8
Frankfurt Am Main 8
Genova 8
London 8
Macerata Campania 8
Ravenna 8
Tripoli 8
Ankara 7
Totale 9.772
Nome #
Helicobacter pylori. Benedetto il giorno che ti ho incontrato 1.299
Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale. 519
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 218
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 215
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 180
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 168
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial 157
A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibility 154
H. pylori antibiotic resistance and 13C urea breath test values. 148
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 140
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 136
13C-urea breath test values and Helicobacter pylori eradication 136
Effects of Helicobacter pylori eradication on early-stage gastric mucosa associated lymphoid tissue lymphoma. 134
Cross-sectional study: CagA-positive helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide 132
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 129
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 124
A human domain antibody and Lewisb–glyconjugate that inhibit binding of Helicobacter pylori to Lewisb receptor and inhibit bacterial adhesion to human gastric epithelium 123
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 123
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 120
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance. 119
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 119
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 119
Accuracy of urea breath tests tablets after 10 minutes compared to standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomised controlled trial 118
A combination of faecal tests for the detection of colon cancer: a new strategy for appropriate selection of referrals to colonoscopy ? A prospective multicenter italian study. 115
Test rapido per la determinazione della chemiosensibilità dell'Helicobacter pylori 114
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 110
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 110
Are Helicobacter Species and Enterotoxigenic Bacteroides fragilis Involved in Inflammatory Bowel Disease? 109
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 109
Phenotypic and genotype H. pylori Clarithromycin resistance and therapeutic outcomes: benefit and limits. 107
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease 107
The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori 107
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature 107
Treatment of Helciobacter pylori infection 2014 106
Gastroesophageal Reflux Disease and Barrett’s Esophagus 106
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 106
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 105
How useful is the rapid urease test for evaluating the success of Helicobacter pylori eradication therapy? 103
In vivo dissolution of levothyroxine soft gel capsules 103
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis 103
E-test for Metronidazole Susceptibility Q1 in H pylori: Use of the Wrong Standard May Have Led to the Wrong Conclusion: Reply 101
La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. 99
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 99
Diagnosi dell'infezione da Helicobacter pylori 99
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 96
Helicobacter pylori and functional dyspepsia: an unsolved issue? 95
Serological markers for gastric atrophy in asymptomatic subjects infected with Helicobacter pylori. 95
Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for Clarithromycin resistance in Helicobacter pylori. 95
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 95
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 95
Diagnosi dell’infezione da Helicobacter pylori 93
An Atlas of Investigation and Management: HELICOBACTER PYLORI 93
Management of helicobacter pylori infection-the Maastricht V/Florence consensus report 93
Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic patients 92
Treatment of Helicobacter pylori infection 91
Helicobacter pylori: current status and future prospects 91
Glaucoma and Helicobacter pylori: Eyes wide shut? 91
Diagnosis of Helicobacter pylori: invasive and non- invasive tests 91
Valutazione dell’accuratezza del nuovo urea breath test a lettura rapida nell’infezione da Helicobacter pylori. 90
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 90
Nuove terapie per curare l’infezione da Helicobacter pylori 89
Considerable use of furazolidone in Iran. 89
Failure of first line eradication treatment significantly increases prevalence of anti-microbial resistant helicobacter pylori clinical isolates. 88
Colonization by Helicobacter pylori of leprosy patients in Spain: immunomodulation to low molecular weight antigens of H pylori 88
The prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid nineties: an 18-yr longitudinal study based on anti-endomysial antibodies 87
Stool test for Helicobacter pylori 86
Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori 86
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 86
Twice daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomised controlled trial using standard and double doses of omeprazole within a triple therapy 85
Global eradication rates for helicobacter pylori infection: systematic review and meta-analysis of sequantial therapy 85
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 85
Quantification of Serum Levels of Pepsinogens and Gastrin to Assess Eradication of Helicobacter Pylori 85
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children 84
A Systematic Review on Drugs Absorption Modifications after Eradication in Helicobacter pylori Positive Patients undergoing Replacement Therapy 84
Sequential therapy for H. pylori: an “aberrant” therapy ready for general use. 83
Attuali criteri di terapia dell’infezione da Helicobacter pylori. New treatment of Helicobacter pylori infection 83
null 83
The sequential therapy regimen for Helicobacter pylori eradication. 82
Attuali criteri di terapia dell'infezione da Helicobacter pylori 82
Treatment of Helicobacter Pylori in Latin America 82
Efficacy of 5-ASA in the treatment of colonic diverticular disease. 82
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT 82
Comparison of image analysis software packages in the assessment af adhesion of microorganism of mucosal epithelium using confocal laser scanning microscopy 81
Peptic ulcer and Helicobacter pylori. 81
null 81
Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori 81
Response to Dr Osato and Graham 80
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 80
Sequential therapy for H pylori eradication: is Levofloxacin better? 80
Expression of COX-2, mPGE synthase 1, MDR-1 (P-GP) and BCL-XL: a molecular pathway of H pylori related-gastric carcinogenesis. 80
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 80
How often do you fail to take all of your medication? 80
Therapy for H. pylori: Current concepts 79
Is Double-Dose Esomeprazole With Bismuth Really Safe? 79
Letter: years of life that could be saved by preventing HCC 79
Infezione da Helicobacter pylori e nuovi orientamenti terapeutici: la terapia sequenziale 78
Diagnosi non invasiva e terapia per Helicobacter Pylori 78
The A2143G point mutation of Clarithromycin resistance affects H. pylori eradication 77
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 77
Growth and adult height in atypical coeliac patients, with or without growth hormone deficiency. 77
Totale 11.835
Categoria #
all - tutte 43.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.276


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019191 0 0 0 0 0 0 0 0 0 0 0 191
2019/20203.682 610 115 71 230 316 345 447 465 430 247 111 295
2020/20211.957 445 163 83 92 36 92 43 120 142 117 99 525
2021/20222.935 308 81 181 295 292 137 60 219 91 92 706 473
2022/20233.143 317 376 185 343 170 237 129 184 588 143 316 155
2023/20243.276 486 337 191 293 188 295 170 130 145 361 431 249
Totale 16.572